Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients - Douglas, Cameron M; Barnard, Richard; Holder, Daniel; Leavitt, Randi; Levitan, Diane; Maguire, Maureen; Nickle, David; Teal, Valerie; Wan, Hong; van Alewijk, Dirk C J G; van Doorn, Leen-Jan; Chou, Sunwen; et al. (The Journal of infectious diseases, 2020)
Keywords: Acetates - pharmacology; Acetates - therapeutic use; Antibiotic Prophylaxis; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Antiviral drugs; Cell culture; Clinical trials; Clinical Trials, Phase III as Topic; Cytomegalovirus; Cytomegalovirus - drug effects; Cytomegalovirus - genetics; Cytomegalovirus Infections - drug therapy; Cytomegalovirus Infections - prevention & control; Cytomegalovirus Infections - virology; Deoxyribonucleic acid; DNA; Drug Resistance, Viral - drug effects; Drug Resistance, Viral - genetics; Ganciclovir; Genotyping; Hematopoietic Stem Cell Transplantation; Hematopoietic stem cells; Humans; Major and Brief Reports; Mutation - genetics; Nucleotide sequence; Phenotyping; Prophylaxis; Quinazolines - pharmacology; Quinazolines - therapeutic use; Randomized Controlled Trials as Topic; Stem cell transplantation; Stem cells; Terminase; Transplants & implants; letermovir; antiviral drug resistance; cytomegalovirus; prophylaxis; RAV